Aquavit Pharmaceuticals

Media

AQUAGOLD® fine touch featured at Winter Clinical Dermatology Meeting

Kohala Coast, HAWAII, January 19, 2014

AQUAGOLD® fine touch was featured at the 2014 Winter Clinical Dermatology Conference in Hawaii during a session on “New Procedures for the Aging Face”. Dr. Mark Nestor, Director of the Center for Cosmetic Enhancement® and Director of the Center for Clinical and Cosmetic Research in Aventura, Florida, introduced AQUAGOLD® fine touch, a unique microneedle device that effectively and comfortably delivers small droplets of treatment solutions directly into the skin allowing for greater absorption of the active ingredients. AQUAGOLD® fine touch treatments provide an enhanced ability to address fine lines, increase collagen stimulation and improve overall moisture and rejuvenation of the skin. Dr. Nestor also presented how the AQUAGOLD® fine touch device can be used in combination with other common procedures such as Botox Cosmetic®, Juvederm®, Restylane® and many other aesthetic treatments.

The Winter Clinical Dermatology Conference is designed to provide the practicing dermatologist with a comprehensive update on the diagnosis and treatment of a variety of conditions related to medical, surgical and appearance dermatology.

Dr. Mark Nestor is also a Voluntary Associate Professor of the Department of Dermatology and Cutaneous Surgery at the University Of Miami Leonard Miller School Of Medicine and co-chairman of the Board of Directors of Advanced Dermatology Management. Dr. Nestor is a past President of the American Society for Photodynamic Therapy, the International Society for Cosmetic and Laser Surgeons, and Florida Society of Dermatology and Dermatologic Surgery.

About Aquavit Pharmaceuticals, Inc.

Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies. For more information, visit www.aquavitpharma.com or www.aquagoldfinetouch.com.